Edition:
United Kingdom

Leap Therapeutics Inc (LPTX.OQ)

LPTX.OQ on NASDAQ Stock Exchange Global Market

6.35USD
17 Oct 2018
Change (% chg)

-- (--)
Prev Close
$6.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,877
52-wk High
$10.25
52-wk Low
$4.94

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.501
Mar '18 0.00 -0.853
FY 2017 Dec '17 0.00 -1.643
Sep '17 0.00 -0.725
Jun '17 0.00 -0.735
Mar '17 0.00 -1.391
FY 2016 Dec '16 0.00 -0.610
Sep '16 0.00 -0.774
Jun '16
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 3 0.00 0.00 0.00 0.00
Quarter Ending Mar-19 2 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 0.00
Year Ending Dec-19 3 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-18 3 -0.46 -0.37 -0.51 -0.79
Quarter Ending Mar-19 3 -0.44 -0.38 -0.53 --
Year Ending Dec-18 3 -2.18 -1.91 -2.32 -3.09
Year Ending Dec-19 3 -1.66 -1.38 -1.81 -2.63
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.83 33.69
P/E High - Last 5 Yrs. -- 288.76 45.21
P/E Low - Last 5 Yrs. -- 90.17 23.79
Beta -- 0.93 0.88
Price to Sales (TTM) -- 123.60 5.82
Price to Book (MRQ) 2.73 15.31 4.89
Price to Tangible Book (MRQ) 2.73 14.52 6.52
Price to Cash Flow (TTM) -- 70.45 22.95
% Owned Institutions 59.23 14.08 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.55 5.39
Payout Ratio(TTM) -- 16.83 43.91

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 413.48 8.02
Sales (TTM) vs TTM 1 Yr. Ago -- 103.91 5.75
Sales - 5 Yr. Growth Rate -- 30.81 9.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 24.33 23.65
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 37.81 10.95
Capital Spending - 5 Yr. Growth Rate -- 38.61 14.90

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.94 2.25
Current Ratio (MRQ) 4.74 5.34 3.05
LT Debt to Equity (MRQ) 0.00 34.95 12.73
Total Debt to Equity (MRQ) 0.00 36.76 17.15
Interest Coverage (TTM) -48.77 -97.17 37.58

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.15 54.90
Gross Margin - 5 Yr. Avg. -- 49.21 52.43
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -575.88 11.08
Operating Margin (TTM) -- -770.08 4.31
Operating Margin - 5 Yr. Avg. -- -596.20 6.43
Pre-Tax Margin (TTM) -- -732.14 5.36
Pre-Tax Margin - 5 Yr. Avg. -- -601.79 6.86
Net Profit Margin (TTM) -- -733.08 1.64
Net Profit Margin - 5 Yr. Avg. -- -604.76 3.11
Effective Tax Rate (TTM) -- 23.64 23.24
Effective Tax Rate - 5 Yr. Avg. -- 18.79 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,788,701 810,573,943
Net Income/Employee (TTM) -1,396,524 1,717,126 95,338,757
Receivable Turnover (TTM) -- 19.81 5.77
Inventory Turnover (TTM) -- 2.38 3.62
Asset Turnover (TTM) 0.00 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -222.52 -1.09 10.92
Return on Assets - 5 Yr. Avg. -- 3.20 12.03
Return on Investment (TTM) -4,400.15 0.58 14.30
Return on Investment - 5 Yr. Avg. -- 2.28 15.63
Return on Equity (TTM) -- 1.62 16.03
Return on Equity - 5 Yr. Avg. -- 3.07 16.90
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -112.71 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Leap Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 62.52%
# of Holders: 25
Total Shares Held: 9,190,514
3 Mo. Net Change: -570
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.